Literature DB >> 19475693

Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex.

M Isabel Lucena1, Raúl J Andrade, Neil Kaplowitz, Miren García-Cortes, M Carmen Fernández, Manuel Romero-Gomez, Miguel Bruguera, Hacibe Hallal, Mercedes Robles-Diaz, Jose F Rodriguez-González, Jose Maria Navarro, Javier Salmeron, Pedro Martinez-Odriozola, Ramón Pérez-Alvarez, Yolanda Borraz, Ramón Hidalgo.   

Abstract

Increased age and female sex are suggested risk factors for drug-induced hepatotoxicity (DILI). We studied the influence of these variables on the propensity to develop DILI, as well as its clinical expression and outcome. All cases of DILI submitted to the Spanish Registry between April 1994 and August 2007 were analyzed. Six hundred three DILI cases (310 men; mean age, 54 years) showed a similar sex distribution, reaching two peaks in the 40- to 49-year-old and 60- to 69-year-old age groups. No cases were recorded in the 20- to 29-year-old group. Patients aged > or =60 years accounted for 46% of the cases, with a male predominance (158 males, 118 females; P= 0.009), as opposed to younger patients. Older age was independently associated with cholestatic type of injury (odds ratio for an age interval for 1 year: 1.024 [95% confidence interval: 1.010-1.038]; male/female ratio, 1:2; P = 0.001) and younger age with hepatocellular damage (odds ratio: 0.983 [95% confidence interval: 0.972-0.994]; female/male ratio, 1:2; P = 0.002). In the mixed group, no age effect was evident. Outcome with fulminant liver failure/liver transplantation was more frequently encountered in women (P < 0.01). conclusion: Neither older age nor female sex are predisposing factors to overall DILI. However, older age is a determinant for cholestatic damage with a male predominance, whereas younger age is associated with cytolytic damage and a female overrepresentation. Women distinctly exhibit the worst outcome. Knowledge of these phenotypic associations could guide differential diagnosis and attribution of causality in DILI.

Entities:  

Mesh:

Year:  2009        PMID: 19475693     DOI: 10.1002/hep.22895

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  74 in total

1.  Suspected Liver Injury and the Dilemma of Causality.

Authors:  Rolf Teschke; Axel Eickhoff
Journal:  Dig Dis Sci       Date:  2017-02-16       Impact factor: 3.199

2.  Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines.

Authors:  Harshad Devarbhavi; Guruprasad Aithal; Sombat Treeprasertsuk; Hajime Takikawa; Yimin Mao; Saggere M Shasthry; Saeed Hamid; Soek Siam Tan; Cyriac Abby Philips; Jacob George; Wasim Jafri; Shiv K Sarin
Journal:  Hepatol Int       Date:  2021-02-27       Impact factor: 6.047

Review 3.  Strategies for Early Prediction and Timely Recognition of Drug-Induced Liver Injury: The Case of Cyclin-Dependent Kinase 4/6 Inhibitors.

Authors:  Emanuel Raschi; Fabrizio De Ponti
Journal:  Front Pharmacol       Date:  2019-10-24       Impact factor: 5.810

4.  Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work.

Authors:  Ayako Suzuki; Raul J Andrade; Einar Bjornsson; M Isabel Lucena; William M Lee; Nancy A Yuen; Christine M Hunt; James W Freston
Journal:  Drug Saf       Date:  2010-06-01       Impact factor: 5.606

5.  Hepatobiliary Quiz (Answers)-16 (2015).

Authors:  Sahaj Rathi; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2015-12-21

6.  Azathioprine and 6-Mercaptopurine-induced Liver Injury: Clinical Features and Outcomes.

Authors:  Einar S Björnsson; Jiezhun Gu; David E Kleiner; Naga Chalasani; Paul H Hayashi; Jay H Hoofnagle
Journal:  J Clin Gastroenterol       Date:  2017-01       Impact factor: 3.062

Review 7.  Risk factors for idiosyncratic drug-induced liver injury.

Authors:  Naga Chalasani; Einar Björnsson
Journal:  Gastroenterology       Date:  2010-04-12       Impact factor: 22.682

Review 8.  Epidemiology and Genetic Risk Factors of Drug Hepatotoxicity.

Authors:  Jawad Ahmad; Joseph A Odin
Journal:  Clin Liver Dis       Date:  2016-10-14       Impact factor: 6.126

Review 9.  Drug-induced liver injury in the elderly.

Authors:  Jonathan G Stine; Praveen Sateesh; James H Lewis
Journal:  Curr Gastroenterol Rep       Date:  2013-01

10.  Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.

Authors:  Naga Chalasani; Herbert L Bonkovsky; Robert Fontana; William Lee; Andrew Stolz; Jayant Talwalkar; K Rajendar Reddy; Paul B Watkins; Victor Navarro; Huiman Barnhart; Jiezhun Gu; Jose Serrano
Journal:  Gastroenterology       Date:  2015-03-06       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.